| 代谢综合征对慢性肾脏病患者生存预后的影响 |
| |
| 引用本文： | 代谢综合征对慢性肾脏病患者生存预后的影响.代谢综合征对慢性肾脏病患者生存预后的影响[J].首都医学院学报,2021,42(4):609-614. |
| |
| 作者姓名： | 代谢综合征对慢性肾脏病患者生存预后的影响 |
| |
| 作者单位： | 1.北京大学第三医院老年内科,北京 100191; 2.首都医科大学宣武医院肾内科,北京 100053 |
| |
| 基金项目： | 国家自然科学基金面上项目(81170706,81341022)。 |
| |
| 摘 要： | 目的 明确代谢综合征(metabolic syndrome,MS)对慢性肾脏病(chronic kidney disease,CKD) 1~5期患者生存预后的影响。方法 选取2006年1月至2008年9月于北京大学第三医院肾内科规律复诊的CKD患者作为研究对象。收集所有研究对象的一般资料、化验检查结果。随访截止时间为2016年12月31日,以全因死亡作为终点事件,采用Kaplan-Meier法及Cox回归分析筛选出影响CKD患者生存预后的独立危险因素。结果 共纳入CKD分期为1~5期并完成随访的存活患者881例,其中合并MS者307例,未合并MS者574例。共有82例患者随访死亡。单因素生存分析及多因素Cox回归分析结果显示,年龄≥65岁、血清白蛋白<42 g/L、合并MS、合并心脑血管疾病是影响CKD患者生存预后的独立危险因素(P<0.05)。结论 MS是影响CKD 1~5期患者生存预后的独立危险因素,合并MS的CKD 1~5期患者死亡风险增大。
|
| 关 键 词： | 代谢综合征 慢性肾脏病 生存预后 危险因素 |
| 收稿时间： | 2020-09-08 |
Effect of metabolic syndrome on survival outcome of chronic kidney disease |
| |
| Lai Xuan,Zhang Aihua.Effect of metabolic syndrome on survival outcome of chronic kidney disease[J].Journal of Capital University of Medical Sciences,2021,42(4):609-614. |
| |
| Authors: | Lai Xuan Zhang Aihua |
| |
| Affiliation: | 1. Department of Geriatrics, Peking University Third Hospital, Beijing 100191, China; 2. Department of Nephrology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China |
| |
| Abstract: | Objective To investigate the the effect of metabolic syndrome (MS) on survival outcomes in patients with chronic kidney disease (CKD) stage 1-5. Methods The patients with CKD from January 2006 to September 2008 in the Department of Nephrology of Peking University Third Hospital were enrolled as the subjects of study. General data and laboratory results of all subjects were collected. The follow-up ended on December 31, 2016, with the all-cause death as the end point event. Kaplan-Meier method and Cox regression analysis were used to screen out independent risk factors for CKD survival outcome. Results A total of 881 survival patients with CKD stage 1-5 were enrolled and completed the follow-up, including 307 with MS and 574 without MS. Totally 82 patients died at the end point of follow-up. Survival analysis showed that age ≥65 years old, serum albumin＜42 g/L, MS and cardiovascular and cerebrovascular diseases were independent risk factors for survival prognosis of CKD patients(P<0.05). Conclusions Metabolic syndrome is an independent risk factor for survival outcomes of CKD 1-5 patients, and the risk of death of CKD stage 1-5 patients with MS is increased. |
| |
| Keywords: | metabolic syndrome chronic kidney disease survival prognosis risk factors |
|
| 点击此处可从《首都医学院学报》浏览原始摘要信息 |
|
点击此处可从《首都医学院学报》下载全文 |
|
